|
Category:information only not used for fragrances or flavors
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 160.00 °C. @ 760.00 mm Hg
|
| Vapor Pressure: | 2.297000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 128.00 °F. TCC ( 53.60 °C. ) (est)
|
| logP (o/w): | 0.779 (est) |
| Soluble in: |
| | water, 3.618e+004 mg/L @ 25 °C (est) |
Organoleptic Properties:
| Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intraperitoneal-mouse LD > 500 mg/kg
"Summary Tables of Biological Tests," National Research Council Chemical-Biological Coordination Center. Vol. 6, Pg. 221, 1954.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | | information only not used for fragrances or flavors |
| Recommendation for 2,4-hexane dione usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for 2,4-hexane dione flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | acetone, propionyl- | | | hexane-2,4-dione | | 2,4- | hexanedione | | | propionylacetone |
Articles:
| PubMed:Effect of the capping ligand on luminescent erbium(III) β-diketonate single-ion magnets. |
| PubMed:Structure and NIR-luminescence of ytterbium(III) beta-diketonate complexes with 5-nitro-1,10-phenanthroline ancillary ligand: assessment of chain length and fluorination impact. |
| PubMed:Synthesis and structures of tridentate ketoiminate zinc complexes bearing trifluoromethyl substituents that act as L-lactide ring opening polymerization initiators. |
| PubMed:Feruloylacetone as the model compound of half-curcumin: synthesis and antioxidant properties. |
| PubMed:Metal extraction from water and organic solvents into fluorous solvents by fluorinated beta-diketone and its application to the colorimetric analysis of metal ions. |
| PubMed:Quantitative structure-activity relationship studies for prediction of antimicrobial activity of synthesized 2,4-hexadienoic acid derivatives. |
| PubMed:Perfluorocarbon-based liquid-liquid extraction for separation of transition metal ions. |
| PubMed:The role of water in drug-receptor interactions. |
| PubMed:Richness of isomerism in labile octahedral Werner-type cobalt(II) complexes demonstrated by 19F NMR spectroscopy: structure and stability. |
| PubMed:Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy. |
| PubMed:Amino acid and protein targets of 1,2-diacetylbenzene, a potent aromatic gamma-diketone that induces proximal neurofilamentous axonopathy. |
| PubMed:Analysis of the in vitro inhibition of murine and human tumor cell growth by pyrazole derivatives and a substituted azabicyclo [3.1.0] hexane-2,4-dione. |
| PubMed:Synthesis of the O-(2,3,4,5,6-pentafluorobenzyl)hydroxylamine oximes of selected carbonyl compounds and their determination by liquid chromatography with ultraviolet detection. |
| PubMed:Hypolipidemic activity of 6-alkoxycarbonyl-3-aryl-1,3,5- triazabicyclo[3.1.0]hexane-2,4-diones and 2-alkoxycarbonyl-5-aryl-1,3,5-triazine-4,6(1H,5H)-diones in rodents. |
| PubMed:Synthesis, characterization and biodistribution of tris(beta-diketonato)technetium(III) complexes. |
| PubMed:Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activity. |
| PubMed:Effect of hexacarbons on selected lipids in developing rat brain and peripheral nerves. |
| PubMed:Hexahydrocarbon effects on intermediate filament organization in human fibroblasts. |
| PubMed:Further observations on in vitro and in vivo effects of 2,5-hexanedione on glyceraldehyde-3-phosphate dehydrogenase. |
| PubMed:[An experimental study on neurotoxicity of 2,5-hexanedione. Visual and somatosensory cortical evoked potentials in rats]. |
| PubMed:Molecular mechanism of hexane neuropathy: significant differences in pharmacokinetics between 2.3-, 2.4-, and 2.5-hexanedione. |
| PubMed:Ultrastructural studies of the dying-back process. VI. Examination of nerve fibers undergoing giant axonal degeneration in organotypic culture. |
| PubMed:Covalent binding of a neurotoxic n-hexane metabolite: conversion of primary amines to substituted pyrrole adducts by 2,5-hexanedione. |
| PubMed:Urinary excretion of n-hexane metabolites. A comparative study in rat, rabbit and monkey. |
| PubMed:The relationship of glucose utilization and morphological change in the visual system in hexacarbon neuropathy. |
| PubMed:Ultrastructural studies of the dying-back process. V. Axonal neurofilaments accumulate at sites of 2,5-hexanedione application: evidence for nerve fibre dysfunction in experimental hexacarbon neuropathy. |
| PubMed:Adenosine cyclic 3',5',-monophosphate phosphodiesterasr inhibitors. 2.3-Substituted 5,7-dialkylpyrazolo [1,5-a]pyrimidines. |
|
3D/inchi